ATR · NASDAQ · STOCK
AptarGroup
$135.46
52W $103.23 – $146.91
57/100
$8.64B
24.2
0.39
⚠
Buy rating, but near-term risk/reward is unfavorable
The long-term recommendation is based on the composite investment score. The near-term risk/reward is based on nearby support and resistance levels. These can differ when a strong company trades close to resistance with support further below.
Is ATR Bullish or Bearish?
Bullish.
Innellis AI committee rates AptarGroup (ATR) Buy with a composite score of 57/100
, based on 5 analysts with 60% agreement.
Last updated August 08, 2026.
What Would Change This View
- Upgrade to Strong Buy
- Requires a committee score of 75.0 — +17.70 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Watch
- Requires the score to fall below 55.0 — -2.30 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
Positive signals support the current rating — market regime is bullish (bull market -- normal position sizing). The committee sees sufficient evidence to maintain the constructive view.
Bull & Bear Case
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
- Market regime is bullish (Bull market -- normal position sizing) — Macro
- News sentiment is positive (+0.20 across 16 articles, 14d) — News
Bear Case
- EPS declining -4.4% YoY despite any revenue growth — Growth
- 2 consecutive earnings misses -- execution concerns — Growth
- MACD histogram negative -- bearish momentum — Technical
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of August 08, 2026
Overall Committee Score
57/100
Agreement
60%
Analysts
5
Conviction
Moderate
Sector Rank
Top 68%
of 95 Healthcare peers
Value Analyst
neutral
58
/ 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
Growth Analyst
neutral
41
/ 100 · High confidence
Moderate growth -- present but not remarkable
+ Quarter-over-quarter growth rate is ACCELERATING, not just positive
− EPS declining -4.4% YoY despite any revenue growth
Technical Analyst
neutral
54
/ 100 · High confidence
Mixed or range-bound price action
+ Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement
− MACD histogram negative -- bearish momentum
Macro Analyst
bullish
70
/ 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst
bullish
64
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.20 across 16 articles, 14d)
Portfolio Manager
neutral
55
/ 100 · Moderate confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− 4 existing position pair(s) are highly correlated already
Investment Thesis Evolution
Committee score moved marginally from 58.8 to 57.3.
- New bearish signals: 1 appeared.
- Bullish support removed: 2 signal(s) disappeared.
- New bullish signals: 1 appeared.
- Analyst(s) changed stance: Technical Analyst.
Analyst-level changes:
- News Analyst: +1 bullish signal(s).
- Technical Analyst: stance bullish->neutral; score 61->54 (-8); +1 bearish signal(s).
Comparing 2026-08-07 to 2026-08-08 (1 day apart).
Technical Analysis
RSI (14)
58.1
Neutral
MACD Histogram
-0.084
Bearish Momentum
Trend Direction
Sideways
Weekly: Sideways
Market Structure
Lh Ll
Support
$131.74
Resistance
$135.79
Bollinger %B
0.69
Inside Bands
Price vs Moving Averages
EMA 9
$135.08
Above
EMA 21
$132.48
Above
EMA 50
$128.25
Above
EMA 200
$128.50
Above
Fundamental Analysis
Valuation
79
Growth
53
Profitability
54
Financial Health
83
Cash Flow
70
Valuation
P/E Ratio
24.2×
P/B Ratio
3.29×
PEG Ratio
-4.61
Dividend Yield
1.42%
52W High
$146.91
52W Low
$103.23
Quality & Growth
ROE
1472.2%
ROA
747.8%
Gross Margin
2826.1%
Operating Margin
1237.0%
Revenue Growth YoY
—
Debt / Equity
0.54
AI Fundamental Assessment
P/E ratio of 24.2 (inexpensive relative to a 15-40x range); Price-to-book of 3.3x; PEG ratio of -4.6 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 14.7%; Return on assets of 7.5%; Net margin of 9.2%; Gross margin of 28.3%; Current ratio of 1.61 (healthy short-term liquidity); Debt-to-equity of 0.54; Free cash flow per share is positive (4.86); Most recent quarter missed estimates by 3.9%; 2 consecutive earnings misses; EPS growth accelerating (-4.8% -> +19.3% QoQ); Average YoY EPS growth of -14.5%; Analyst estimates rising over recent quarters
Get the Full ATR Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →